McLaughlin Gavin, Baumann Michael H, Kavanagh Pierce V, Morris Noreen, Power John D, Dowling Geraldine, Twamley Brendan, O'Brien John, Hessman Gary, Westphal Folker, Walther Donna, Brandt Simon D
Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland.
Forensic Science Ireland, Garda Headquarters, Dublin, Ireland.
Drug Test Anal. 2018 Sep;10(9):1404-1416. doi: 10.1002/dta.2396. Epub 2018 May 23.
The availability of new psychoactive substances (NPS) on the recreational drug market continues to create challenges for scientists in the forensic, clinical and toxicology fields. Phenmetrazine (3-methyl-2-phenylmorpholine) and an array of its analogs form a class of psychostimulants that are well documented in the patent and scientific literature. The present study reports on two phenmetrazine analogs that have been encountered on the NPS market following the introduction of 3-fluorophenmetrazine (3-FPM), namely 4-methylphenmetrazine (4-MPM), and 3-methylphenmetrazine (3-MPM). This study describes the syntheses, analytical characterization, and pharmacological evaluation of the positional isomers of MPM. Analytical characterizations employed various chromatographic, spectroscopic, and mass spectrometric platforms. Pharmacological studies were conducted to assess whether MPM isomers might display stimulant-like effects similar to the parent compound phenmetrazine. The isomers were tested for their ability to inhibit uptake or stimulate release of tritiated substrates at dopamine, norepinephrine and serotonin transporters using in vitro transporter assays in rat brain synaptosomes. The analytical characterization of three vendor samples revealed the presence of 4-MPM in two of the samples and 3-MPM in the third sample, which agreed with the product label. The pharmacological findings suggest that 2-MPM and 3-MPM will exhibit stimulant properties similar to the parent compound phenmetrazine, whereas 4-MPM may display entactogen properties more similar to 3,4-methylenedioxymethamphetamine (MDMA). The combination of test purchases, analytical characterization, targeted organic synthesis, and pharmacological evaluation of NPS and their isomers is an effective approach for the provision of data on these substances as they emerge in the marketplace.
新型精神活性物质(NPS)在娱乐性毒品市场上的出现,继续给法医、临床和毒理学领域的科学家带来挑战。苯甲曲秦(3-甲基-2-苯基吗啉)及其一系列类似物构成了一类精神兴奋剂,在专利和科学文献中有充分记载。本研究报告了在3-氟苯甲曲秦(3-FPM)出现后,在NPS市场上遇到的两种苯甲曲秦类似物,即4-甲基苯甲曲秦(4-MPM)和3-甲基苯甲曲秦(3-MPM)。本研究描述了MPM位置异构体的合成、分析表征和药理学评价。分析表征采用了各种色谱、光谱和质谱平台。进行药理学研究以评估MPM异构体是否可能表现出与母体化合物苯甲曲秦相似的兴奋样作用。使用大鼠脑突触体中的体外转运体测定法,测试了这些异构体抑制多巴胺、去甲肾上腺素和5-羟色胺转运体上氚标记底物摄取或刺激其释放的能力。对三个供应商样品的分析表征显示,其中两个样品中存在4-MPM,第三个样品中存在3-MPM,这与产品标签一致。药理学研究结果表明,2-MPM和3-MPM将表现出与母体化合物苯甲曲秦相似的兴奋特性,而4-MPM可能表现出与3,4-亚甲基二氧甲基苯丙胺(MDMA)更相似的致幻特性。对NPS及其异构体进行试购、分析表征、有针对性的有机合成和药理学评价相结合,是在这些物质出现在市场上时提供相关数据的有效方法。